MedTrace Logo

Early Detection of Cardiac Impairment and Prediction of RV Hypertrophy in Patients With CTD

NCT04297371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 136

Last updated 2020-08-13

No results posted yet for this study

Summary

There have been reports suggesting that progressive RV failure and death in connective tissue disease (CTD) are related to right ventricular hypertrophy (RVH) and dilation, irrespective of pulmonary arterial hypertension (PAH). The investigators aim to identify cardiac markers that occur before RVH and to investigate predictors of RVH.

Conditions

  • Connective Tissue Diseases
  • Right Ventricular Hypertrophy

Interventions

DIAGNOSTIC_TEST

CMR examination

After recruiting participants and collecting the baseline information, a CMR scan and a post-processed imaging procedure will be carried on in order to detect the cardiac impairment.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Meng Jiang, MD · RenJi Hospital, School of Medicine, Shanghai Jiantong University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04297371 on ClinicalTrials.gov